Funding Details
- Date Award
- May 13, 2024
- Vertical
- Biotech
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2020
- Traction
- CyclicBio has made significant progress in developing its synthetic biology platform and has attracted strategic partnerships with key players in the biotechnology and healthcare sectors. The company's innovative approach to cyclic peptide design has garnered attention for its potential to revolutionize drug discovery and industrial biotechnology applications.
- Company Description
- CyclicBio is a biotechnology company specializing in developing novel therapeutics using synthetic biology approaches. The company's focus is on engineering cyclic peptides for various applications in healthcare, agriculture, and industrial biotechnology. CyclicBio's proprietary platform enables the rapid design and optimization of cyclic peptides with enhanced stability, specificity, and efficacy, offering a versatile solution for addressing unmet needs in multiple industries.
- Market
- Biotechnology
- Location
-
San Francisco,
CA,
US
- Coinvestors
- SOSV
Links